Clinical Trial Update: Natural Dendritic Cell Vaccines in Metastatic Melanoma Patients [Phase 1]

View source ↗

Summary

Phase 1 study evaluating natural dendritic cell vaccines in metastatic melanoma patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Natural Dendritic Cell Vaccine (Dendritic cell vaccine)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Melanoma | Phase 1 | Status: COMPLETED